Amphetamine Extended Release Tablets

· Tris Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Amphetamine Extended Release Tablets, covering 2022-02-18 to 2023-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD [Phase 3]